503 — Lansen Pharmaceutical Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall Cap

Annual balance sheet for Lansen Pharmaceutical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11.6	20.4	116	32.5	51.3
Net Total Accounts Receivable
Net Total Receivables	44.3	43.5	40.4	47.8	44.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	108	111	190	115	132
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	28.3	27.8	26.8	25.2	21.3
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	202	184	253	172	184
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	111	80.5	51.5	53.5	60
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	113	82.6	55.5	55.7	62
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	88.5	101	197	117	122
Total Liabilities & Shareholders' Equity	202	184	253	172	184
Total Common Shares Outstanding